跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENBREL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ENBREL
Authorized
STANDARD
ENBREL
Immunex Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a4b04d464816a119
Company
Immunex Corporation
Type
Standard
Approval Details
Approval Id
a4b04d464816a119
Drug Approval Canada Name
ENBREL
Product Name
ENBREL
Status
Cancelled Post Market
Status Date
2023-01-31
Original Market Date
2001-03-14
Din
02242903
Drug Class
Human
Dosage Form
Kit , Powder For Solution , Liquid
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
90:24.16.92
Atc Original
L04AB01 ETANERCEPT
Atc Name
l 04 ab 01
Aig Number
0242101001
Company Name
Immunex Corporation
Company Address
One Amgen Centre Drive, Thousand Oaks, California, United States, 91320-1799
Company Detail Path
/organization/immunex-corporation
Company Information
Pharmaceutical Company Name
Immunex Corporation
Country Name
United States
Province Name
Washington
City Name
seattle,washington,country_us
Address
51 University St
Active Ingredients
ETANERCEPT
25 MG / KIT
WATER
1 ML / KIT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a4b04d464816a119
Type
Standard
Back to Health Canada Approvals